This year’s focus lies on research to support sustainability and the development of next-generation genomic tools in agriculture / Researchers will receive funding and mentorship resources from Bayer to further advance their pioneering work and grow with mentorship from industry leaders

MONHEIM, Germany, May 25, 2023 /CSRwire/ – Bayer today announced its 2023 cohort of Grants4Ag grant recipients who have been selected to research promising sustainability and biotechnology subjects in agriculture with support from Bayer. The annual program provides both financial and mentorship resources, with awards ranging from 5,000 to 15,000 Euro in addition to access to some of Bayer’s leading Crop Science researchers as mentors for the duration of the program. This year’s program addressed three innovation themes integral to Bayer’s R&D efforts in its Crop Science division: sustainability traits, plant transformation technologies, and the gene editing potential of local plant varieties.

“The Grants4Ag program can make a direct impact on the future of agriculture and drive food security and sustainability going forward,” said Dr. Phil Taylor, Director of Open Innovation and Outreach for Bayer’s Crop Science Division. “We will be working with some of the best and brightest researchers from leading academic institutions around the world and are looking forward to advance innovations together.”

Grants4Ag awardees retain all intellectual property rights to their research. In addition to financial awards, successful researchers will also be paired with Bayer scientists to provide project guidance as their research progresses. With support from innovation partnering platform Halo, Bayer received more than 100 proposals from researchers around the world during a five-week submission window this past fall.

Previous grant awardee Prof. Ji Zhou of the National Institute of Agricultural Botany in Cambridge, UK reflected on how his experience as a Grants4Ag recipient helped develop his team’s research into wheat and rice, two critical crops for global food security: “The support we’ve received through the Bayer Grants4Ag program has enabled us to consolidate our proof-of-principle studies on dynamic phenotyping in wheat and rice,” said Prof. Ji Zhou. The 2022 awardee added: “Through the Grants4Ag program, not only have we had opportunities to engage with our Bayer contacts, but we also worked with Bayer’s global phenotyping and breeding teams to verify new ideas and set up new projects in areas such as AI-powered trait analysis and in-field root phenotyping, bridging requirement gaps by working with a global leader and helping to address breeding bottlenecks.”

2023 Grants4Ag Awardees

Sustainability Traits:

Amit Dhingra, Texas A&M AgriLife Research, USA
Leslie A Weston, Charles Sturt University, Australia
Li-Qing Chen, University of Illinois Urbana-Champaign, USA
Manqiang Liu, Nanjing Agricultural University, China
Owen Rowland, Carleton University, Canada

Plant Transformation:

Heqiang Huo, University of Florida, USA
Claudia Osorio, Instituto de Investigaciones Agropecuarias, Chile
Kirankumar Mysore, Oklahoma State University, USA
Steven Strauss, Oregon State University, USA
Christine Ondzighi-Assoume, Tennessee State University, USA
Zheng Gong, University of Queensland, Australia
Chinenye Izuegbunam, University of South Dakota, USA
Guo-Qing Song, Michigan State University, USA
Randy Allen, Oklahoma State University, USA
Bastiaan Bargmann, Virginia Polytechnic Institute and State University, USA
Megan Kelly, University of Florida, USA
Penny Hundleby & Tom Lawrenson, John Innes Centre, UK

Gene Editing of Local Varieties:

Karen Massel, University of Queensland, Australia.
Samuel Acheampong, University of Cape Coast, Ghana.
Ihuoma Okwuonu, National Root Crops Research Institute, Umudike, Nigeria
Sara Zenoni, Universita degli Studi di Verona, Italy

About Bayer
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2022, the Group employed around 101,000 people and had sales of 50.7 billion euros. R&D expenses before special items amounted to 6.2 billion euros. For more information, go to www.bayer.com.

Find more information at www.bayer.com.
Follow us on twitter.com/bayer

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

View original content here.

Contact

Alexander Hennig
Media Relations
alexander.hennig@bayer.com

Bayer

Bayer

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.

More from Bayer